Announcement: Aurelia Bioscience has been acquired by Charnwood Molecular.

Share this

We have brought together a suite of cutting-edge, market-leading biophysical technologies to provide insights into molecular interactions in many different project settings.

We believe that biophysical techniques can dovetail well with our integrated drug discovery projects – working in tandem with biochemical or cell biology-based assays to quickly return binding data to our DMPK and medicinal chemistry colleagues. Equally, our biophysics suite can be used for standalone projects to definitively measure and characterise the binding of one molecule to another.

Find out more about the techniques we offer:

You can find out more about our full bioscience capabilities here.